(Q35953264)

11 August 2017

1 reference

title

Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review (English)

1 reference

11 August 2017

2

Rainer Storb

1 reference

11 August 2017

Frédéric Baron

1

1 reference

11 August 2017

publication date

29 July 2004

1 reference

Seminars in Immunopathology

11 August 2017

published in

1 reference

11 August 2017

volume

26

1 reference

11 August 2017

issue

1-2

1 reference

11 August 2017

page(s)

71-94

1 reference

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat

11 August 2017

cites work

1 reference

12 December 2020

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

12 December 2020

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

12 December 2020

History of haematopoietic stem-cell transplantation.

1 reference

12 December 2020

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

12 December 2020

One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation

1 reference

12 December 2020

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

12 December 2020

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1 reference

12 December 2020

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

1 reference

12 December 2020

Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation

1 reference

12 December 2020

Bone-marrow transplantation (second of two parts).

1 reference

12 December 2020

What radiation dose for DLA-identical canine marrow grafts?

1 reference

12 December 2020

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

12 December 2020

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.

1 reference

12 December 2020

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

12 December 2020

Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

1 reference

12 December 2020

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

12 December 2020

Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings

1 reference

12 December 2020

Hematopoietic cell transplantation for benign hematological disorders and solid tumors.

1 reference

12 December 2020

Maximizing optimal hematopoietic stem cell donor selection from registries of unrelated adult volunteers

1 reference

12 December 2020

Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes

1 reference

12 December 2020

Graft-versus-leukemia reactions in allogeneic chimeras

1 reference

12 December 2020

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

1 reference

12 December 2020

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

1 reference

12 December 2020

Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants

1 reference

12 December 2020

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

12 December 2020

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

12 December 2020

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation

1 reference

12 December 2020

Recovery from radiation injury

1 reference

12 December 2020

Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression

1 reference

12 December 2020

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

12 December 2020

Allogeneic marrow grafting for acute lymphoblastic leukemia: leukemic relapse

1 reference

12 December 2020

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

1 reference

12 December 2020

DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment

1 reference

12 December 2020

Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

1 reference

12 December 2020

Marrow transplanation in man following cyclophosphamide

1 reference

12 December 2020

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

12 December 2020

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

12 December 2020

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

12 December 2020

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Marrow grafts by combined marrow and leukocyte infusions in unrelated dogs selected by histocompatibility typing

1 reference

12 December 2020

1994 Consensus Conference on Acute GVHD Grading

1 reference

12 December 2020

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

12 December 2020

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

1 reference

12 December 2020

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

1 reference

12 December 2020

T-cell depletion of HLA-identical transplants in leukemia.

1 reference

12 December 2020

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

12 December 2020

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

12 December 2020

T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation

1 reference

12 December 2020

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

12 December 2020

A compendium of reported human bone marrow transplants

1 reference

12 December 2020

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

1 reference

12 December 2020

Marrow transplantation for patients with acute lymphoblastic leukemia in remission

1 reference

12 December 2020

National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants

1 reference

12 December 2020

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1 reference

12 December 2020

Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses

1 reference

12 December 2020

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

1 reference

12 December 2020

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

12 December 2020

Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemia

1 reference

12 December 2020

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

12 December 2020

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

1 reference

12 December 2020

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients

1 reference

12 December 2020

Modification of irradiation injury in mice and guinea pigs by bone marrow injections

1 reference

12 December 2020

Identical-twin bone marrow transplants for leukemia.

1 reference

12 December 2020

Marrow transplantation for the treatment of chronic myelogenous leukemia

1 reference

12 December 2020

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

12 December 2020

Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy

1 reference

12 December 2020

Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts

1 reference

12 December 2020

Cytotoxic typing antisera for marrow grafting in littermate dogs

1 reference

12 December 2020

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

12 December 2020

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase

1 reference

12 December 2020

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

1 reference

12 December 2020

Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease

1 reference

12 December 2020

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

12 December 2020

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1 reference

12 December 2020

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

12 December 2020

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

1 reference

12 December 2020

Chronic graft-versus-host disease

1 reference

12 December 2020

Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts

1 reference

12 December 2020

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

12 December 2020

10.1007/S00281-004-0165-3

Identifiers

DOI

1 reference

release_vmhhbpvqpnbbtkp2dngqcskuk4

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vmhhbpvqpnbbtkp2dngqcskuk4

24 November 2022

mapped directly with Wikidata item

1 reference